glp-1 receptor agonists mechanism of action of [25] Discovery of GLP-1–Based Drugs for

Landin K, Tengborn L, Smith U (1991) Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

Alharbi planned the study, performed an extensive literature review, evaluated the available data, developed the improved figures including quantitative meta-analysis data, and wrote the manuscript

Gariani and Putzu 2024)

However, continuous research and vigilant monitoring are essential to optimize their safe use [55] [56], particularly as these medications are used in broader populations for longer durations

Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations